Language:
English
Change Language
English
français
español
العربيّة
Русский
简体中文
Português
Hausa
Hindi
Bahasa
اردو
Menu
Search
Home
News
Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), 08 March 2022
8 March 2022 │ Statement
Eighth Meeting of the Multilateral Leaders Task Force on COVID-19, 1 March 2022: "Third Consultation with the CEOs of leading vaccine manufacturers"
7 March 2022 │ Statement
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs
7 March 2022 │ Statement
WHO updates its treatment guidelines to include molnupiravir
3 March 2022 | News release
COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide
2 March 2022 | News release
Dangerously low medical oxygen supplies in Ukraine due to crisis, warn WHO Director-General and WHO Regional Director for Europe
27 February 2022 │ Statement
Statement on Omicron sublineage BA.2
22 February 2022 │ Statement
WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners
18 February 2022 │ News release
WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19
11 February 2022 │ Departmental news
South Africa’s mRNA hub progress is foundation for self-reliance
11 February 2022 │ News release
< Prev
1
2
...
5
6
7
8
9
...
32
31
Next >
Search
Case Stats
News
Vaccine updates
Protect yourself
Information for healthcare workers
Your questions answered